Patent · US Active

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

US11459332B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2019
Grant dateOct 4, 2022
Priority date—
Expiry dateMar 13, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are certain TRK inhibitors of formula (I): pharmaceutical compositions thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.